3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
10
Phase NA
3
Phase 1/2
2
Phase 4
1
Phase 3
1
Phase 1
1
Status
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Lymphoid
1
Dermatologic
1
Conditions
Precursor Cell Lymphoblastic Leukemia-Lymphoma
48
Leukemia
41
Breast Neoplasms
28
Lymphoma
21
Leukemia, Myeloid, Acute
16
Burkitt Lymphoma
13
Myelodysplastic Syndromes
11
Graft vs Host Disease
10
Lymphoma, Non-Hodgkin
7
Lymphoma, Large B-Cell, Diffuse
7
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
7
Leukemia, Biphenotypic, Acute
7
Squamous Cell Carcinoma of Head and Neck
6
Urinary Bladder Neoplasms
5
Leukemia, Promyelocytic, Acute
5
Hodgkin Disease
5
Anemia, Refractory, with Excess of Blasts
5
Osteosarcoma
4
Myeloproliferative Disorders
4
Lymphoma, Follicular
4
Leukemia, Myelomonocytic, Chronic
4
Head and Neck Neoplasms
4
Arthritis, Rheumatoid
4
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
3
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
3
Lymphoma, Large-Cell, Immunoblastic
3
Lymphoma, Large-Cell, Anaplastic
3
Leukemia, Myeloid, Chronic-Phase
3
Leukemia, Myeloid, Accelerated Phase
3
Leukemia, Lymphocytic, Chronic, B-Cell
3
Interventions
liposomal amphotericin B
2
hypericin
2
Phototherapy
2
Peripheral Blood Stem Cell Transplantation
2
Methoxsalen
2
Levofloxacin
2
Early Intervention, Educational
2
Darbepoetin alfa
2
Bexarotene
2
zanolimumab
1
ferrous sulfate
1
ferric gluconate
1
Vorinostat
1
Valacyclovir
1
Ultraviolet Therapy
1
Sucrose
1
Radiotherapy
1
Psychiatric Rehabilitation
1
Pharmacogenomic Testing
1
Ondansetron
1
Moxifloxacin
1
Morphine
1
Methotrexate
1
Lenalidomide
1
Ketamine
1
Itraconazole
1
Fluconazole
1
Filgrastim
1
Fentanyl
1
Epoetin Alfa
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 3
×
Mycosis Fungoides
×
Methotrexate
×
Clear all
NCT01578499
2021-01-05
ALCANZA
Takeda
Phase 3
Completed
131 enrolled
24 charts